Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Regulators of G protein signaling (
RGS
proteins) interact with Galpha(q) and Galpha(i) and accelerate GTPase activity. These proteins have been characterized only within the past few years, so our understanding of their importance is still preliminary. We examined the effect of
oxytocin
on RGS2 mRNA expression to help determine the role of
RGS
proteins in
oxytocin
signaling in human myometrial cells in primary culture.
Oxytocin
increased RGS2 mRNA concentration maximally by 1 or 2 h in a dose-dependent and agonist-specific manner. RGS2 mRNA levels were also elevated by treatment with Ca(2+) ionophore, phorbol ester, or forskolin.
Oxytocin
's effects were completely inhibited by an intracellular Ca(2+) chelator and partially blocked by a protein kinase C inhibitor, indicating that intracellular Ca(2+) concentration is the primary signal for
oxytocin
elevation of RGS2 mRNA levels. Use of pharmacological inhibitors indicated that part of
oxytocin
-stimulated RGS2 mRNA expression is mediated by G(i)/tyrosine kinase activities. Although
oxytocin
does not stimulate increases in intracellular cAMP concentration, agents that elevate intracellular cAMP concentrations and cause myometrial relaxation may possibly cause heterologous desensitization to
oxytocin
via RGS2 expression. These results suggest that RGS2 may be important in regulating the myometrial response to
oxytocin
.
...
PMID:Oxytocin stimulation of RGS2 mRNA expression in cultured human myometrial cells. 1183 60